|
| 產(chǎn)地 | 進口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS9642 |
| 應用范圍 | WB=1:100-500 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-phospho-TrkB (Tyr705) |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated Synthesised phosphopeptide derived from rat NTRK2 around the phosphorylation site of Tyr705 |
抗體的生物素化標記實驗要點：
1. 磷酸化酪氨酸激酶B抗體規(guī)格 如在反應混合液中有疊氮鈉或游離氨基存在,會抑制標記反應。因此,蛋白質(zhì)在反應前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當則影響標記的效率,應先用幾個不同的分子比來篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結(jié)合位點可能因此被封閉,導致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等；
5.當游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團,如羰基、氨基、巰基、異咪唑基及*基,也可與糖基共價結(jié)合；
7.交聯(lián)反應后,應充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用；
8.在細胞的熒光標記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細胞可導致高本底。
產(chǎn)品訂購信息：
英文名稱 Anti-phospho-TrkB (Tyr705)
中文名稱 磷酸化酪氨酸激酶B抗體規(guī)格
別 名 TrkB (Phospho-Tyr705); phospho-NTRK2(Tyr705); NTRK2(phospho Y705); TrkB; Tyrosine Receptor Kinase B; Tyrosine kinase,Pyk2; BDNF tropomyosine receptor kinase B; BDNF/NT 3 growth factors receptor; BDNF/NT-3 growth factors receptor; Brain derived neurotrophic factor receptor; GP145 TrkB; GP145-TrkB; GP145-TrkB/GP95-TrkB; GP95 TrkB; Neurotrophic tyrosine kinase receptor type 2; Neurotrophin receptor tyrosine kinase type 2; NTRK 2; Ntrk2; NTRK2_HUMAN; Obesity, hyperphagia, and developmental delay, included; RATTRKB1; Tkrb; Trk B; Trk-B; TRKB; TrkB tyrosine kinase; TRKB1; tyrosine kinase receptor B; Tyrosine receptor kinase B.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 免疫學 神經(jīng)生物學 信號轉(zhuǎn)導 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 92kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from rat NTRK2 around the phosphorylation site of Tyr705
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化酪氨酸激酶B抗體規(guī)格 產(chǎn)品應用 WB=1:100-500 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The Trk family of nerve growth factor receptors includes Trk A(also referfed to as Trk A gp140),Trk B and Trk C. The prototype member of this gene family, Trk A, encodes a 140 kDa cell surface receptor, gp140, the expression of which is restricted in vivo to neurons of the sensory spinal and cranial gangliaof neurocrest origin. Nerve growth factor (NGF) stimulates tyrosine phosphorylation of Trk gp 140 in neural cell lines and in embryonic dorsal root ganglia. By comparison, BDNF and to a lesser extent, NT-3, but not NGF, can induce tyrosine phophorylayion of Trk B gp 145. The third member of the Trk receptor family, Trk C incodes a 140 kDa protein, Trk C gp140, that is preferentially expressed in brain tissue and primarily functions as a receptor for NT-3.An additional component of the Trk receptor complex, NGFR p175, binds to neurotrophic factors with low affinity but is required for efficient signaling. NGFR p175 accelerates Trk activation and may recruit downstream dffector molecules to the ligand-bound receptor complex.
Function : Receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems through regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity. Receptor for BDNF/brain-derived neurotrophic factor and NTF4/neurotrophin-4. Alternatively can also bind NTF3/neurotrophin-3 which is less efficient in activating the receptor but regulates neuron survival through NTRK2. Upon ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades. Through SHC1, FRS2, SH2B1, SH2B2 activates the GRB2-Ras-MAPK cascade that regulates for instance neuronal differentiation including neurite outgrowth. Through the same effectors controls the Ras-PI3 kinase-AKT1 signaling cascade that mainly regulates growth and survival. Through PLCG1 and the downstream protein kinase C-regulated pathways controls synaptic plasticity. Thereby, plays a role in learning and memory by regulating both short term synaptic function and long-term potentiation. PLCG1 also leads to NF-Kappa-B activation and the transcription of genes involved in cell survival. Hence, it is able to suppress anoikis, the apoptosis resulting from loss of cell-matrix interactions. May also play a role in neutrophin-dependent calcium signaling in glial cells and mediate communication between neurons and glia.Subunit : Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Interacts (phosphorylated upon activation by BDNF) with SHC1; mediates SHC1 phosphorylation and activation. Interacts (phosphorylated upon activation by BDNF) with PLCG1 and/or PLCG2; mediates PLCG1 phosphorylation and activation. Interacts with SH2B1 and SH2B2. Interacts with NGFR; may regulate the ligand specificity of the receptor. Interacts (phosphorylated upon ligand-binding) with SH2D1A; regulates NTRK2. Interacts with SQSTM1 and KIDINS220. Interacts (phosphorylated upon ligand-binding) with FRS2; activates the MAPK signaling pathway.Subcellular Location : Cell membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein. Note=Internalized to endosomes upon ligand-binding.Tissue Specificity : Isoform TrkB is expressed in the central and peripheral nervous system. In the central nervous system (CNS), expression is observed in the cerebral cortex, hippocampus, thalamus, choroid plexus, granular layer of the cerebellum, brain stem, and spinal cord. In the peripheral nervous system, it is expressed in many cranial ganglia, the ophtalmic nerve, the vestibular system, multiple facial structures, the submaxillary glands, and dorsal root ganglia. Isoform TrkB-T1 is mainly expressed in the brain but also detected in other tissues including pancreas, kidney and heart. Isoform TrkB-T-Shc is predominantly expressed in the brain.Post-translational modifications : Phosphorylated. Undergoes ligand-mediated autophosphorylation that is required for interaction with SHC1 and PLCG1 and other downstream effectors. Isoform TrkB-T-Shc is not phosphorylated.Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor (By similarity).DISEASE : Defects in NTRK2 are the cause of obesity hyperphagia and developmental delay (OHPDD) [MIM:613886]. OHPDD is a disorder characterized by early-onset obesity, hyperphagia, and severe developmental delay in motor function, speech, and language.Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.Contains 2 Ig-like C2-type (immunoglobulin-like) domains.Contains 2 LRR (leucine-rich) repeats.Contains 1 LRRCT domain.Contains 1 LRRNT domain.Contains 1 protein kinase domain.Database links : UniProtKB/Swiss-Prot: Q16620.1NGF, BDNF, NT-3, NT-4等的受體包括trkA, trkB, trkC及NGFR。BDNF, NT-3能誘導trkB的酪氨酸磷酸化。(神經(jīng)生長因子受體的一種)
抗體的鑒定：
1）磷酸化酪氨酸激酶B抗體規(guī)格 抗體的效價鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應,瓊脂擴散試驗,酶聯(lián)免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴散試驗來鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應抗原或近似抗原物質(zhì)的識別能力。抗體的特異性高,它的識別能力就強。衡量特異性通常以交叉反應率來表示。交叉反應率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結(jié)合率,求出各自在IC50時的濃度,并按公式計算交叉反應率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質(zhì)的交叉反應率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。
FADD (Fas-associated protein with death domain) Fas死亡結(jié)構(gòu)域相關(guān)蛋白抗原Multi-class antibodies規(guī)格： 0.5mg
β-酪蛋白(抗體)兔抗山羊、綿羊 Anti-Beta-casein 0.1ml
Rhesus antibody Rh phospho-Eg5(Tyr92) 磷酸化驅(qū)動蛋白樣蛋白1抗體 規(guī)格 0.1ml
胎血清(特優(yōu)級) 500ml Hyclone
ZNF263 英文名稱： 鋅指蛋白263抗體 0.2ml
DYRK2 英文名稱： 雙特異性酪酸磷酸化調(diào)節(jié)激酶DYRK2抗體 0.2ml
β-酪蛋白(抗體)兔抗山羊、綿羊 Anti-Beta-casein 0.1ml
Gax(growth arrest-specific homeobox) 生長終止特異性同源盒基因抗原Multi-class antibodies規(guī)格： 0.5mg
EPHB4 EphB4 兔單抗 (PE) Human
Rhesus antibody Rh Phospho-DARPP32(Thr34) 磷酸化多巴胺/cAMP調(diào)節(jié)神經(jīng)磷蛋白抗體 規(guī)格 0.1ml
非預染蛋白Marker分子量標準(10-200kDa) 2x250μl/100次 MBI原裝
ZNF307 英文名稱： 鋅指蛋白307抗體 0.2ml
DCTN6 英文名稱： 動力蛋白激活蛋白6抗體 0.2ml
EPHB4 EphB4 兔單抗 (PE) Human
ZBTB5 英文名稱： 鋅指蛋白ZBTB5抗體 0.2ml
Dact2 英文名稱： Dapper2蛋白抗體 0.2ml
膜粘連蛋白 Ⅳ抗體 Anti-Annexin Ⅳ 0.1ml
Anti-ZW10 peptide/FITC 熒光素標記著絲粒蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-ERK1+ERK2(Thr185+Tyr187+Thr202+Tyr204) 磷酸化原活化蛋白激酶ERK抗體 規(guī)格 0.1ml
DCC (Deleted in colorectal cancer gene) 結(jié)缺失基因抗原Multi-class antibodies規(guī)格： 0.5mg
JM培養(yǎng)基基礎(chǔ)250g海博新產(chǎn)品
DPBS，(1X)(IVD) 含鈣鎂離子，不含酚紅 14040-141 100ml incubation media DPBS，(1X)(IVD) 含鈣鎂離子，不含酚紅 14040-141 100ml
灰樹花 支/瓶
Baird-ParkerAgarBase
WLD培養(yǎng)基 250g 用于釀造和工業(yè)發(fā)酵過程中細菌分離培養(yǎng)
麥康凱瓊脂培養(yǎng)基(MacC)250g用于腸道致病菌的選擇性分離培養(yǎng)
卵黃瓊脂基礎(chǔ) 250(g) incubation media 卵黃瓊脂基礎(chǔ) 250(g)
大腸桿菌O157:H7顯色培養(yǎng)基 1000ml 用于大腸桿菌O157:H7的快速分離和鑒定
氣單胞菌培養(yǎng)基添加劑支添加劑加入氣單胞菌培養(yǎng)基基礎(chǔ)incubationmedia氣單胞菌培養(yǎng)基添加劑支添加劑加入氣單胞菌培養(yǎng)基基礎(chǔ)
DifferentiaClostridialAgar
磷酸化酪氨酸激酶B抗體規(guī)格 CIN-1培養(yǎng)基基礎(chǔ) 規(guī)格： 250g 用途： 用于小腸耶爾森氏菌的選擇性分離和培養(yǎng)
改良磷酸鹽緩沖液 規(guī)格： 250g 用途： 用于小腸耶爾森氏菌的增菌培養(yǎng)。
乳糖膽鹽發(fā)酵培養(yǎng)基 規(guī)格： 250g 用途： 用于測定藥品中大腸菌群、糞大腸菌群和大腸桿菌（中華人民共和國藥典2010年版）。
TPY液體培養(yǎng)基 規(guī)格： 250g 用途： 培養(yǎng)雙歧桿菌用于果糖-6-磷酸鹽磷酸酶（F6PPK）測定
|
|
|
|
|
